MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals epigenetic alterations during chronic colitis malignant transformation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Bao, Yonghua ^a   Guo, Yongchen ^a   Li, Zexin ^a   Fang, Wenfeng ^b   Yang, Yiqiong ^a   Li, Xuhan ^a   Li, Zhuangzhuang ^a   Xiong, Bowen ^a   Chen, Zhiguo ^a   Wang, Jianguo ^a   Kang, Kang ^c   Gou, Deming ^c   Yang, Wancai ^a,d  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SHENZHEN UNIVERSITY   (China)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 138; MICRORNA 145; MICRORNA 146A; MICRORNA 150; MUCIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MUC2 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CHRONIC COLITIS; CHRONIC INFLAMMATION; COLITIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; MALIGNANT TRANSFORMATION; MOUSE; MUC2 GENE; NONHUMAN; PHENOTYPE; RECTUM PROLAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CARCINOGENESIS; CHRONIC DISEASE; COLON; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; RECTUM;

ANIMALS; CARCINOGENESIS; CHRONIC DISEASE; COLITIS; COLON; COLORECTAL NEOPLASMS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, KNOCKOUT; MICRORNAS; MUCIN-2; RECTUM; TRANSCRIPTOME;

EID: 84903287457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099132     Document Type: Article

References (56)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: a cancer journal for clinicians 62: 10-29.
2. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170. (Pubitemid 26358996)
3. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, et al. (2013) Cancer genome landscapes. Science 339: 1546-1558.
4. Rustgi AK (2007) The genetics of hereditary colon cancer. Genes Dev 21: 2525-2538.
5. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, et al. (2013) Cancer genome landscapes. Science 339: 1546-1558.
6. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790. (Pubitemid 27136715)
7. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138: 2101-2114 e2105
8. Grivennikov SI (2013) Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 35: 229-244.
9. Danese S, Mantovani A. (2010) Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 29: 3313-3323.
10. Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30: 677-706.
11. Sung JJ, Lau JY, Goh KL, Leung WK (2005) Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6: 871-876. (Pubitemid 41614799)
12. Saleh M, Trinchieri G (2011) Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 11: 9-20.
13. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23: 1097-1104. (Pubitemid 43779348)
14. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535. (Pubitemid 32234798)
15. Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10: 639-645.
16. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S (1996) Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 39: 87-92. (Pubitemid 26239112)
17. Neufert C, Becker C, Neurath MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2: 1998-2004. (Pubitemid 47308138)
18. Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60. (Pubitemid 38082153)
19. Andrianifahanana M, Moniaux N, Batra SK (2006) Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 1765: 189-222. (Pubitemid 44294395)
20. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, et al. (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295: 1726-1729. (Pubitemid 34202910)
21. Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, et al. (2008) Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res 68: 7313-7322.
22. Yang W, Velcich A, Lozonschi I, Liang J, Nicholas C, et al. (2005) Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol 166: 1239-1246. (Pubitemid 40524446)
23. Bi X, Tong C, Dockendorff A, Bancroft L, Gallagher L, et al. (2008) Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis 29: 1435-1440.
24. Tong C, Yin Z, Song Z, Dockendorff A, Huang C, et al. (2007) c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am J Pathol 171: 297-303. (Pubitemid 47339246)
25. Mariadason JM, Nicholas C, L'Italien KE, Zhuang M, Smartt HJ, et al. (2005) Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 128: 1081-1088. (Pubitemid 40523558)
26. Kang K, Zhang X, Liu H, Wang Z, Zhong J, et al. (2012) A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PloS one 7: e48536.
27. Bi X, Pohl NM, Qian Z, Yang GR, Gou Y, et al. (2012) Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33: 326-330.
28. Fang W, Han A, Bi X, Xiong B, Yang W. (2010) Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling. Int J Cancer 127: 32-42.
29. Fang W, Goldberg ML, Pohl NM, Bi X, Tong C, et al. (2010) Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis 31: 1360-1366.
30. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, et al. (2006) Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129. (Pubitemid 44015753)
31. Kanneganti M, Mino-Kenudson M, Mizoguchi E (2011) Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011: 342637.
32. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
33. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
34. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223: 102-115.
35. Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in cancer. Annu Rev Pathol 9: 287-314.
36. Lages E, Ipas H, Guttin A, Nesr H, Berger F, et al. (2012) MicroRNAs: molecular features and role in cancer. Front Biosci (Landmark Ed) 17: 2508-2540.
37. White NM, Fatoohi E, Metias M, Jung K, Stephan C, et al. (2011) Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol 8: 75-84.
38. Ye XW, Yu H, Jin YK, Jing XT, Xu M, et al. (2014) miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells. Clin Respir J.
39. Long L, Huang G, Zhu H, Guo Y, Liu Y, et al. (2013) Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 11: 275.
40. Liu X, Lv XB, Wang XP, Sang Y, Xu S, et al. (2012) MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 11: 2495-2506.
41. Yeh YM, Chuang CM, Chao KC, Wang LH (2013) MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha. Int J Cancer 133: 867-878.
42. Gong H, Song L, Lin C, Liu A, Lin X, et al. (2013) Downregulation of miR-138 sustains NF-kappaB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res 19: 1083-1093.
43. Sen A, Most P, Peppel K (2014) Induction of microRNA-138 by proinflammatory cytokines causes endothelial cell dysfunction. FEBS Lett 588: 906-914.
44. Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, et al. (2013) miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73: 3425-3440.
45. Noguchi S, Yamada N, Kumazaki M, Yasui Y, Iwasaki J, et al. (2013) socs7, a target gene of microRNA-145, regulates interferon-beta induction through STAT3 nuclear translocation in bladder cancer cells. Cell death & disease 4: e482.
46. Wang D, Liu D, Gao J, Liu M, Liu S, et al. (2013) TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration. The FEBS journal 280: 3340-3353.
47. Zhou L, Zhao X, Han Y, Lu Y, Shang Y, et al. (2013) Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27: 4929-4939.
48. Bousquet M, Zhuang G, Meng C, Ying W, Cheruku PS, et al. (2013) miR-150 blocks MLL-AF9-associated leukemia through oncogene repression. Mol Cancer Res 11: 912-922.
49. Morris VA, Zhang A, Yang T, Stirewalt DL, Ramamurthy R, et al. (2013) MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors. PLoS One 8: e75815.
50. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, et al. (2013) Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC genomics 14: 589.
51. Zhu X, Lin Z, Du J, Zhou X, Yang L, et al. (2014) Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia. Molecular and cellular biochemistry 390: 75-84.
52. Trifari S, Pipkin ME, Bandukwala HS, Aijo T, Bassein J, et al. (2013) MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 110: 18608-18613.
53. Zheng Q, Zhou L, Mi QS (2012) MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function. J Immunol 188: 2118-2126.
54. Kumar A, Mohan S, Newton J, Rehage M, Tran K, et al. (2005) Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. The Journal of biological chemistry 280: 37782-37789. (Pubitemid 41642388)
55. Boudiaf-Benmammar C, Cresteil T, Melki R (2013) The cytosolic chaperonin CCT/TRiC and cancer cell proliferation. PloS one 8: e60895.
56. Kawata H, Yamada K, Shou Z, Mizutani T, Yazawa T, et al. (2003) Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. The Biochemical journal 373: 747-757. (Pubitemid 36981084)